A recent study published in the British Medical Journal has shown that even when patients know they're taking a placebo, the ...

For decades, the placebo effect — the phenomenon where ... Then a 2010 study revealed significant effects of open-label placebos for irritable bowel syndrome (IBS). The researchers in the ...

Microdosing might not work the way we think—but that doesn’t mean it doesn’t work. Here’s what science and the placebo effect ...

Open-label placebos are not covered by insurance ... One of the key elements of the placebo effect is the way our expectations shape our experience. As he handed over the pills, Kelley wanted ...

Behavioral adverse effects, including hostility (1.7% ... [97] conducted an open-label, placebo-controlled, double-blind study to determine the safety and efficacy of levetiracetam; this study ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in people with early Alzheimer's disease.

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...

Open-label placebo studies show that participants ... but in how it invites us to harness the placebo effect as a tool for everyday change. References Benedetti, F. (2014). Placebo effects ...